Nyxol Eye Drops $Ocuphire Pharma(OCUP)$ $3.92
PDUFA date of September 28, 2023.
网页链接{Ocuphire Pharma Announces Financial Results for Second Quarter 2...查看全文
美股滚雪球2022-08-16 15:56
$头脑风暴细胞治疗(BCLI)$ 治疗渐冻症的三期失败了,后来又修正了一些数据,现在看到$Amylyx(AMLX)$ 有望获批,以及$Biogen制药(BIIB)$ 的药物获得优先评审,BCLI又开始准备提交BLA查看全文
chuminhua2021-03-05 23:50
3月3日,BrainStorm称,FDA已经通知他们,需要更多的数据,才有望获得其ALS治疗NurOwn的批准,但与此同时,他们仍在宣传疗效的 "明确信号”,且并不排除申请的可能性。一周多后,FDA在一份最不寻常的声明中澄清。
FDA的声明提供了一组不同于该公司去年11月公开介绍的疗效数字,并排除了任...查看全文
chuminhua2021-02-23 23:25
2月22日,BrainStorm Cell Therapeutics表示,FDA认为,该公司在研细胞疗法NurOwn的III期研究中没有足够的 "实质性证据 "来支持肌萎缩侧索硬化症(ALS)的上市申请。据BrainStorm,该机构建议其提供额外的临床数据以支持申请,虽然该建议 "不排除[我们]继续进行......提交",但该...查看全文
$头脑风暴细胞治疗(BCLI)$ 8-K - Current report Filed: 2019-08-02 AccNo: 0001144204-19-037338 Size: 171 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 9.01: Financial Statements and Exhibits 网页链接
$头脑风暴细胞治疗(BCLI)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2019-08-02 AccNo: 0001144204-19-037507 Size: 176 KB 网页链接
$头脑风暴细胞治疗(BCLI)$ 8-K - Current report Filed: 2019-07-26 AccNo: 0001144204-19-036265 Size: 17 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$头脑风暴细胞治疗(BCLI)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-06-11 AccNo: 0001144204-19-030587 Size: 251 KB 网页链接
$头脑风暴细胞治疗(BCLI)$ 8-K - Current report Filed: 2019-06-11 AccNo: 0001144204-19-030589 Size: 295 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$头脑风暴细胞治疗(BCLI)$ 8-K - Current report Filed: 2019-05-13 AccNo: 0001144204-19-025457 Size: 17 KBItem 8.01: Other Events 网页链接
$头脑风暴细胞治疗(BCLI)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-10 AccNo: 0001144204-19-025310 Size: 2 MB 网页链接
$头脑风暴细胞治疗(BCLI)$ 10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-04-01 AccNo: 0001144204-19-017368 Size: 6 MB 网页链接
$头脑风暴细胞治疗(BCLI)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-29 AccNo: 0001144204-19-017041 Size: 7 MB 网页链接
$头脑风暴细胞治疗(BCLI)$ 8-K - Current report Filed: 2019-03-12 AccNo: 0001144204-19-013381 Size: 19 KBItem 7.01: Regulation FD DisclosureItem 8.01: Other Events 网页链接